QCOVID
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

QCOVID Trademark

Serial Number: 79310606 • Registration: 6823030

QCOVID is a trademark filed by Oxford University Innovation Limited on January 20, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Oxford University Innovation Limited (6 trademarks)

Buxton Court 3 West Way
Botley Oxford OX2OSZ , GB

Entity Type: 99

Trademark Details

Filing Date

January 20, 2021

Registration Date

August 23, 2022

Published for Opposition

June 7, 2022

Goods & Services

Educational and training services namely, seminars and online courses in relation to predictive modelling software of the risk of hospitalisation, mortality and morbidity due to Covid-19; providing on-line, non-downloadable electronic publications namely, articles and research papers in the field of predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19; publication of electronic books and journals on-line in the field of predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19

Downloadable predictive modelling computer software for predicting the risk of hospitalisation, mortality and morbidity due to Covid-19; predictive modelling computer software for predicting the risk of hospitalisation, mortality and morbidity due to Covid-19 for use as a downloadable software application; downloadable predictive modelling software for predicting the risk of hospitalisation, mortality and morbidity due to Covid-19; downloadable publications from the Internet, namely, articles in the field of predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19; downloadable predictive modelling databases and electronic data files from the Internet related to the risk of hospitalisation, mortality and morbidity due to Covid-19; downloadable computer software to enable management, storing, searching and retrieval of data for use in the medical and healthcare industries related to predictive modelling of patients data and the associated health risks from Covid-19; downloadable electronic publications provided on-line from databases or the Internet, namely, articles in the field of predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19

Printed matter, namely, articles and research papers featuring information related to predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19; operating manuals and instruction booklets in printed form in the field of predictive modelling of computer software for predicting the risk of hospitalisation, mortality and morbidity due to Covid-19

Licensing of intellectual property rights for technology use in the diagnosis and risk prediction to patients with Covid-19; licensing of medical devices for use in the diagnosis and risk prediction to patients with Covid-19

Medical diagnostic testing services for Covid-19; medical diagnostic, monitoring, and reporting services for Covid-19; medical information about Covid-19 provided on-line from a computer database or from the Internet

Scientific research related to the diagnosis and risk prediction of Covid-19 to patients; design services for others in the field of medical devices used in the risk prediction of Covid-19 to patients; industrial research and design services in the field of risk prediction of Covid-19 to patients; design and development of software for predictive modelling of the risk of hospitalisation, mortality and morbidity due to Covid-19; advisory services, consultancy services, and design services for others in relation to predictive modelling software

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 28, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 1, 2022 FICS
FINAL DISPOSITION PROCESSED
Nov 30, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 23, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 23, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 23, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
ASSIGNED TO LIE
May 2, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 29, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 29, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 29, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 29, 2022 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 29, 2022 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 5, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 18, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 18, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 18, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 18, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 18, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 18, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 18, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 18, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 18, 2022 COAR
REFUSAL PROCESSED BY IB
Sep 20, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 26, 2021 RFCS
REFUSAL PROCESSED BY MPU
Aug 26, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 13, 2021 RFCR
NON-FINAL ACTION WRITTEN
Aug 12, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 6, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
May 18, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 13, 2021 REPR